6932 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Merdury Biopharmaceutical Corp. manufactures pharmaceutical products. It focuses on the development of drugs for unmet medical needs. It develop faster, lower side effects, and more in line with human needs for drugs. The company was founded on July 16, 2019 and is headquartered in New Taipei City. Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
6932 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company